Brazilian IP News – Page 2 – Protecting Your Trademarks & Patents in Brazil

Brazil Pharma IP & Business Intelligence Report – RPI 2853

Get the Full Brazil Pharma IP & BI Report The Brazil Pharma IP & Business Intelligence Report – RPI 2853

INPI Rejects Bradesco’s Nullity Attempts: What the NFTSTAR Case Reveals About IP Strategy

A Landmark Example of Monitoring in Action In September 2025, the Brazilian Patent and Trademark Office (INPI) published its decision

CAS & CAPES ampliam acesso ao CAS BioFinder™ — avanço estratégico para pesquisa e inteligência de patentes no Brasil

CAS & CAPES ampliam acesso ao CAS BioFinder™ — avanço estratégico para pesquisa e inteligência de patentes no Brasil A

USPTO Clarifies §101 Examination for Software, AI & ML: A Playbook for Stronger Claims

Last updated: August 13, 2025Author: Marcus Julius Zanon — IP & Compliance Counsel (MJZanon) USPTO Clarifies §101 Examination for Software,

U.S. Drug Price Reform Accelerates: Trump Targets Pharma CEOs in Bold MFN Policy Revival

U.S. Drug Price Reform Accelerates: Trump Targets Pharma CEOs in Bold MFN Policy Revival By Marcus Julius Zanon –

<script>
  document.addEventListener('wpf_submit_success', function(event, formData) {
    // Unlock the protected content
    const content = document.getElementById('protected-content');
    if (content) {
      content.style.filter = 'none';
      content.style.pointerEvents = 'auto';
    }

    // Close popup
    PUM.closeAll();
  });
</script>

Protecting Your Trademarks & Patents in Brazil